Skip to main content
HLB SCIENCE Inc. logo

HLB SCIENCE Inc. — Investor Relations & Filings

Ticker · 343090 ISIN · KR7343090007 KO Professional, scientific and technical activities
Open in API
Filings indexed 187 across all filing types
Latest filing 2023-02-14 Major Shareholding Noti…
Country KR South Korea
Listing KO 343090

About HLB SCIENCE Inc.

https://hlbscience.com/eng/index.php

HLB SCIENCE Inc. is a biopharmaceutical company specializing in the development of innovative drugs and diagnostics for infectious and immune-related diseases. The company's primary research focuses on creating therapeutics for sepsis, superbacteria infections, and Alzheimer's disease. Its key pipeline candidate for sepsis, DD-S052P, is a novel antibiotic designed to eliminate both bacteria and their associated endotoxins to mitigate cytokine storms. For Alzheimer's disease, HLB SCIENCE is advancing DD-A279, a treatment that modulates lipopolysaccharides (LPS) and gram-negative bacteria in the central nervous system. This therapeutic effort is complemented by the development of DD-A514, a diagnostic kit for the early detection of Alzheimer's.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership, including the acquisition of new shares and convertible bonds by the reporting entity and its special related parties. This document type is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2023-02-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often referred to as a '10% rule' or 'insider ownership' report) to notify the regulator of changes in shareholdings by major shareholders or executives. This falls under the category of 'Director's Dealing' (DIRS) as it details the ownership status and changes in shareholdings by a major shareholder (HLB Global).
2023-02-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by insiders or major shareholders. Based on the provided categories, this falls under 'Director's Dealing' (DIRS) as it reports personal share transactions and ownership changes by a major shareholder (Knotus Co., Ltd.) in the issuing company (HLB Science).
2023-02-14 Korean
증권발행결과(자율공시)(제4회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance method, amount, and payment date. This falls under the category of capital and financing updates, specifically related to the issuance of new debt/equity instruments.
2023-02-09 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from HLB Science, specifically an amendment (정정신고) to a previously filed 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It details corrections to the redemption yield and early redemption terms of the bonds. Since this is a formal regulatory filing regarding capital structure and financing activities (issuance of convertible bonds), it falls under the 'Capital/Financing Update' category.
2023-02-09 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by HLB Science. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-02-09 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.